https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

New findings for the clinical management of patients with schizophrenia

20 de December de 2019

The study of the mechanisms involved in the development and the appearance of the clinical manifestations of schizophrenia can help us improve the clinical capacity in the diagnosis and treatment of this important mental disorder. Previous publications in a cohort of schizophrenia patients, belonging to the “Program of First Episodes of Psychosis in Cantabria” (PAFIP) […]

Read more →

Dr Maria Buti joins the IDIVAL Extensive Scientific Council

18 de December de 2019

This Tuesday, December 17, 2019, the incorporation of Dr. Maria Buti to the External Scientific Council of IDIVAL and the dismissal of Dr. Josep María Grinyo was approved in the Board of Trustees of IDIVAL. Dr. Buti, is head of Hepatology and Internal Medicine at the Vall d'Hebron Hospital, principal investigator of the Hepatic Diseases […]

Read more →

Social isolation is a new key factor in primary care medical consultations

17 de December de 2019

In a recent publication in Applied Research in Quality of Life under the title “Does Social Isolation Affect Medical Doctor Visits? New Evidence Among European Older Adults” professors David Cantarero-Prieto, Marta Pascual-Sáez and Carla Blázquez-Fernández; Members of the R&D Group on Health Economics and Health Services Management UC-IDIVAL study how social isolation affects medical consultations in […]

Read more →

Impact of resisted therapy on motor function in children with cerebral palsy

13 de December de 2019

Muscle weakness in cerebral palsy (CP) contributes to disability to a greater extent than muscle spasticity itself. Previous studies suggest that resisted exercises would increase muscle strength without increasing spasticity, opening the possibility that this increase in strength could be associated simultaneously with improvements in gait or motor function. The results of the meta-analysis published […]

Read more →

Treatment of spasticity of the lower limb after a stroke

11 de December de 2019

The Rehabilitation Service of the Marqués de Valdecilla University Hospital in collaboration with 23 Spanish hospitals and a neurology service has conducted a prospective real-life observational study (Real World Evidence) on the functional improvement of botulinum toxin type A injection in patients with lower limb spasticity after having suffered a stroke. This study is part […]

Read more →

Damage to the retina and optic nerve

25 de November de 2019

The Neurophthalmology Unit of the Liencres-HUMV Hospital has studied the involvement of retinal structures (ganglion cells) and optic nerve (nerve fiber layer) in patients with mild cognitive impairment and Alzheimer's Disease (AD) using coherence tomography optical (OCT). In this study, published in the journal 'Alzheimers Dement (N Y)' the authors analyze the use of the […]

Read more →

Phages as an aid for antibiotics

21 de November de 2019

Antibiotics are medications that destroy or inactivate bacteria. These drugs are very useful against infections, but the misuse we have made of them in recent decades has caused them to lose their ability to destroy pathogenic bacteria. This is because bacteria have begun to become resistant to many antibiotics at once. Modern medicine rests on […]

Read more →

Reliability and profitability of glaucoma diagnostic protocols

20 de November de 2019

The Neurophthalmology and Glaucoma Unit of the Liencres-HUMV Hospital has studied the correlation of visual fields with the results of optical coherence tomography (OCT) in a study that includes 161 patients. In this study, published in the journal 'PlosOne', the authors analyze the reliability of two protocols for the diagnosis and follow-up of glaucoma, one […]

Read more →

Hypoxia Can Induce Migration of Glioblastoma Cells Through a Methylation-Dependent Control of ODZ1 Gene Expression

12 de November de 2019

Glioblastoma, is the most frequent malignant tumor of the Central Nervous System and, due to its heterogeneity and its high capacity for local invasion, in most cases it has a poor prognosis, despite current treatment protocols. One of the characteristics of the glioblastoma microenvironment is hypoxia, generated by rapid tumor growth. The invasive capacity of […]

Read more →

Defining the genetic architecture of Parkinsons disease in Spain

5 de November de 2019

Researchers from the Neurodegenerative Diseases Group of IDIVAL have participated in the first study of genomic association (GWAs) in Parkinson's disease carried out in Spain. This is a study that has had the participation of 13 Spanish centers and has included 7,849 subjects with Parkinson's disease and healthy controls. The study has served to characterize […]

Read more →